{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:52:43Z","timestamp":1780987963386,"version":"3.54.1"},"reference-count":34,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Bristol Myers Squibb"},{"name":"Seagen"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2026,1,2]]},"DOI":"10.1080\/14796694.2025.2599082","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:44:00Z","timestamp":1765356240000},"page":"93-99","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Nivolumab plus brentuximab vedotin for relapsed\/refractory diffuse large B-cell lymphoma"],"prefix":"10.1080","volume":"22","author":[{"given":"Nathalie A.","family":"Johnson","sequence":"first","affiliation":[{"name":"Jewish General Hospital","place":["Montreal, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Zinzani","sequence":"additional","affiliation":[{"name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia \u201cSer\u00e0gnoli\u201d","place":["Bologna, Italy"]},{"name":"Universit\u00e0 di Bologna","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Domingo-Domenech","sequence":"additional","affiliation":[{"name":"Hospital Duran i Reynals, IDIBELL","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Brody","sequence":"additional","affiliation":[{"name":"Mount Sinai School of Medicine","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Kline","sequence":"additional","affiliation":[{"name":"University of Chicago","place":["Chicago, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijal Dinesh","family":"Shah","sequence":"additional","affiliation":[{"name":"Moffitt Cancer Center","place":["Tampa, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitkumar Nitinkumar","family":"Mehta","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham","place":["Birmingham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herve","family":"Ghesquieres","sequence":"additional","affiliation":[{"name":"Hopital Lyon Sud","place":["Pierre-B\u00e9nite, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry J.","family":"Savage","sequence":"additional","affiliation":[{"name":"British Columbia Cancer Agency","place":["Vancouver, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Barr","sequence":"additional","affiliation":[{"name":"University of Rochester","place":["Rochester, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Santoro","sequence":"additional","affiliation":[{"name":"Humanitas University","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Ospedale Papa Giovanni XXIII","place":["Bergamo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Royal Marsden Hospital","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham P.","family":"Collins","sequence":"additional","affiliation":[{"name":"Churchill Hospital","place":["Oxford, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Fanale","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Bothell, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Krajewski","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb","place":["Princeton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alev","family":"Akyol","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb","place":["Princeton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Crowe","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb","place":["Boudry, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Wen","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb","place":["Princeton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kuruvilla","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre","place":["Toronto, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2011.1.498"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011795"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.901365"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2301665"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLML.2010.n.030"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2660"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0855"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.778407"},{"key":"e_1_3_8_12_1","unstructured":"Bristol Myers Squibb. Opdivo\u00ae (nivolumab) package insert. [cited 21 May 2025]. Available from: https:\/\/packageinserts.bms.com\/pi\/pi_opdivo.pdf"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00315"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.9789"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00766"},{"key":"e_1_3_8_16_1","unstructured":"Seagen. Adcetris\u00ae (brentuximab vedotin) prescribing information. [cited 21 May 2025]. Available from: https:\/\/docs.seagen.com\/Adcetris_Full_Ltr_Master.pdf"},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.0402"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-598763"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009178"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-23-0118"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01492"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017951"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2136956"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-282780"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-764258"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000303"},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-10-811224"},{"key":"e_1_3_8_29_1","unstructured":"Genentech. Polivy\u00ae (polatuzumab vedotin-piiq) prescribing information. [cited 21 May 2025]. Available from: https:\/\/www.gene.com\/download\/pdf\/polivy_prescribing.pdf"},{"key":"e_1_3_8_30_1","unstructured":"Bristol Myers Squibb. Breyanzi\u00ae (lisocabtagene maraleucel) prescribing information. [cited 21 May 2025]. Available from: https:\/\/packageinserts.bms.com\/pi\/pi_breyanzi.pdf"},{"key":"e_1_3_8_31_1","unstructured":"Kite Pharmaceuticals. Yescarta\u00ae (axicabtagene ciloleucel) prescribing information. [cited 21 May 2025]. Available from: https:\/\/www.gilead.com\/-\/media\/files\/pdfs\/medicines\/oncology\/yescarta\/yescarta-pi.pdf"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02410-8"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206913"},{"key":"e_1_3_8_34_1","unstructured":"Genmab Medicines. Epkinly\u00ae (epcoritamab-bysp) prescribing information. [cited 21 May 2025]. Available from: https:\/\/www.genmab-pi.com\/prescribing-information\/epkinly-pi.pdf"},{"key":"e_1_3_8_35_1","unstructured":"Genentech. Columvi\u00ae (glofitamab-gxbm) prescribing information. [cited 21 May 2025]. Available from: https:\/\/www.gene.com\/download\/pdf\/columvi_prescribing.pdf"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA7005"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2025.2599082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T13:40:55Z","timestamp":1767361255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2025.2599082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"alternative-id":["10.1080\/14796694.2025.2599082"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2025.2599082","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-05-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}